Biography:
Dr. Waleed Mohammed Al-Shaqha is an Associate Professor at the College of Medicine, Imam Mohammad ibn Saud Islamic University in Riyadh, Saudi Arabia. He holds both a Doctor of Pharmacy (PharmD) and a PhD, reflecting his extensive expertise in the pharmaceutical field. Beyond his academic role, Dr. Al-Shaqha serves as the Chairman of the Board of Directors at CAD Middle East Pharmaceutical Industries LLC (CAD). During the COVID-19 pandemic, he also took on the responsibilities of Chief Executive Officer (CEO) to guide the company through challenging times. CAD focuses on producing active pharmaceutical ingredients (APIs) for small molecules, offering a diverse range of generic medicines across various therapeutic categories.
In addition to his leadership roles, Dr. Al-Shaqha has contributed significantly to pharmaceutical literature. Notably, he authored the 4th Edition of the "Saudi National Formulary (SNF)," a comprehensive medical reference published in 2009. His research interests encompass medicine, clinical pharmacology, basic pharmacology, pharmacy practice, and cardiology. His scholarly work has been widely recognized, with his publications cited over 950 times, underscoring his impact on the field. Through his multifaceted career, Dr. Al-Shaqha has made substantial contributions to both the academic and practical aspects of pharmaceutical sciences, playing a pivotal role in advancing healthcare in Saudi Arabia.
Title : Enabling Active Pharmaceutical Ingredient Industry in Saudi Arabia